Preclinical CRO Market Is Estimated To Exhibit At USD 9.67 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi9yE0HdjKAN8rNJXM8aEhADlsstdJhKRSEiX7T8ItCeEt55GTWNIyAyw1d3I5I-Ljb4d-xYgX3pdRJmcPifK1mqJNqGXluuthy-2UlUqvOHmA7hlWsPxn436y9yZLXRyYtTZ_2gF7Mus7KZyi_UlDD2WRkKuWYpvbtqZqC452T-cgF6U5Zhg5zU5a-wQ/s320/Preclinical%20CRO%20Market.png)
San Francisco, 28 Feb 2023: The Report Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2022 - 2030 The global preclinical CRO market size is expected to reach USD 9.67 billion by 2030, expanding at a CAGR of 7.9%, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market during the forecast period. However, the COVID-19 pandemic had temporarily affected the market owing to the shutdown of research sites due to the implementation of national lockdowns. The market is undergoing a series of mergers and acquisitions, resulting in improvement in full-service capabilities and the internatio